AI-generated summary
The authors studied HeLa cervical cancer cells in vitro, treating them with cisplatin or zoledronic acid followed by low-level laser therapy. They report that laser alone increased cell viability, while combining laser with either drug enhanced the drugs' effects on cell metabolism and reduced viability. The authors suggest laser may raise chemotherapy cytotoxicity, though this is a laboratory cell study.
- Who or what was studied
- HeLa cervical cancer cells cultured in vitro
- Limits stated in the abstract
- The study used cultured cells in vitro rather than patients or animals, so results may not translate to clinical use.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ar.iiarjournals.org.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.